Cardio IQ® Diabetes and ASCVD Risk Panel with Scores
Test Code
Clinical Significance
Cardio IQ® Diabetes and ASCVD Risk Panel with Scores - To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Cardio IQ® Hemoglobin A1c
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® Risks and Personal Factors
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.
Methodology
Reference Range(s)
For additional information, please refer to: http://education.QuestDiagnostics.com/faq/FAQ142
(This link is being provided for informational/educational purposes only.)
Alternative Name(s)
Preferred Specimen(s)
4 mL serum collected in a Serum separator tube (SST) and 1 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
2 mL serum • 0.5 mL whole blood
Collection Instructions
For risk calculations to be performed, the following patient-specific information must be provided at the time of order:
Age: Years
Gender: M (for male) or F (for female)
Race - African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Treatment for High B.P.: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Smoking Status: Y (for yes) or N (for no)
Transport Container
Serum separator tube (SST) and EDTA (lavender-top) tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Serum
- Room temperature: 48 hours
- Refrigerated: 7 days
- Frozen: 28 days
- Whole blood
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: 6 months
Reject Criteria
Gross hemolysis • Unspun serum or plasma separator tube (SST or PST) • Red-top or green-top tube (serum or heparanized plasma not separated from cells) • Red-top tube (no gel) • Moderate to grossly icteric • Sodium fluoride/oxalate (grey-top) tube • Heparinized plasma
Setup Schedule
Age: Years
Gender: M (for male) or F (for female)
Race - African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Treatment for High B.P.: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Smoking Status: Y (for yes) or N (for no)
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 28 days
Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months